Work

Rapid hyperacute intracranial deterioration following initiation of ipilimumab/nivolumab in BRAF V600E-mutant melanoma of unknown primary with brain metastases after BRAF/MEK inhibitor therapy: a case series

Year: 2026

Type: article

Study design: Case Report

Source: Melanoma Research

DOI: 10.1097/cmr.0000000000001098

Authors: Maja Ivanova, Igor Stojkovski, Violeta Klisarovska

Institutions: University Clinic for Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7150863861

FWCI:

Cites: 9

Cited by:

Related to: